These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38953453)

  • 21. Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major.
    Omolabi KF; Iwuchukwu EA; Odeniran PO; Soliman MES
    Comput Biol Chem; 2021 Feb; 90():107412. PubMed ID: 33199197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosomal dihydrofolate reductase reveals natural antifolate resistance.
    Vanichtanankul J; Taweechai S; Yuvaniyama J; Vilaivan T; Chitnumsub P; Kamchonwongpaisan S; Yuthavong Y
    ACS Chem Biol; 2011 Sep; 6(9):905-11. PubMed ID: 21650210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of 1,3,4-Oxadiazole Derivatives as Broad-Spectrum Antiparasitic Agents.
    Corfu AI; Santarem N; Luelmo S; Mazza G; Greco A; Altomare A; Ferrario G; Nasta G; Keminer O; Aldini G; Tamborini L; Basilico N; Parapini S; Gul S; Cordeiro-da-Silva A; Conti P; Borsari C
    ACS Infect Dis; 2024 Jun; 10(6):2222-2238. PubMed ID: 38717116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and Genetic Tests for Inhibitors of Leishmania Pteridine Pathways.
    Hardy LW; Matthews W; Nare B; Beverley SM
    Exp Parasitol; 1997 Nov; 87(3):158-70. PubMed ID: 9398595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.
    Dawson A; Gibellini F; Sienkiewicz N; Tulloch LB; Fyfe PK; McLuskey K; Fairlamb AH; Hunter WN
    Mol Microbiol; 2006 Sep; 61(6):1457-68. PubMed ID: 16968221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical and genetic validation of dihydrofolate reductase-thymidylate synthase as a drug target in African trypanosomes.
    Sienkiewicz N; Jarosławski S; Wyllie S; Fairlamb AH
    Mol Microbiol; 2008 Jul; 69(2):520-33. PubMed ID: 18557814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
    Mpamhanga CP; Spinks D; Tulloch LB; Shanks EJ; Robinson DA; Collie IT; Fairlamb AH; Wyatt PG; Frearson JA; Hunter WN; Gilbert IH; Brenk R
    J Med Chem; 2009 Jul; 52(14):4454-65. PubMed ID: 19527033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of novel inhibitors of Trypanosoma brucei pteridine reductase 1.
    Spinks D; Ong HB; Mpamhanga CP; Shanks EJ; Robinson DA; Collie IT; Read KD; Frearson JA; Wyatt PG; Brenk R; Fairlamb AH; Gilbert IH
    ChemMedChem; 2011 Feb; 6(2):302-8. PubMed ID: 21275054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a cytochrome c-coupled assay for pteridine reductase 1 and dihydrofolate reductase.
    Shanks EJ; Ong HB; Robinson DA; Thompson S; Sienkiewicz N; Fairlamb AH; Frearson JA
    Anal Biochem; 2010 Jan; 396(2):194-203. PubMed ID: 19748480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma brucei DHFR-TS Revisited: Characterisation of a Bifunctional and Highly Unstable Recombinant Dihydrofolate Reductase-Thymidylate Synthase.
    Gibson MW; Dewar S; Ong HB; Sienkiewicz N; Fairlamb AH
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004714. PubMed ID: 27175479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
    Nare B; Luba J; Hardy LW; Beverley S
    Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trypanosoma brucei dihydrofolate reductase-thymidylate synthase: gene isolation and expression and characterization of the enzyme.
    Gamarro F; Yu PL; Zhao J; Edman U; Greene PJ; Santi D
    Mol Biochem Parasitol; 1995 Jun; 72(1-2):11-22. PubMed ID: 8538681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.
    Ferrari S; Morandi F; Motiejunas D; Nerini E; Henrich S; Luciani R; Venturelli A; Lazzari S; Calò S; Gupta S; Hannaert V; Michels PA; Wade RC; Costi MP
    J Med Chem; 2011 Jan; 54(1):211-21. PubMed ID: 21126022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors.
    Panecka-Hofman J; Pöhner I; Spyrakis F; Zeppelin T; Di Pisa F; Dello Iacono L; Bonucci A; Quotadamo A; Venturelli A; Mangani S; Costi MP; Wade RC
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3215-3230. PubMed ID: 28939533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
    Magoulas GE; Afroudakis P; Georgikopoulou K; Roussaki M; Borsari C; Fotopoulou T; Santarem N; Barrias E; Tejera Nevado P; Hachenberg J; Bifeld E; Ellinger B; Kuzikov M; Fragiadaki I; Scoulica E; Clos J; Gul S; Costi MP; de Souza W; Prousis KC; Cordeiro da Silva A; Calogeropoulou T
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kaurane-Type Diterpenoids as Potential Inhibitors of Dihydrofolate Reductase-Thymidylate Synthase in New World
    Herrera-Acevedo C; de Menezes RPB; de Sousa NF; Scotti L; Scotti MT; Coy-Barrera E
    Antibiotics (Basel); 2023 Mar; 12(4):. PubMed ID: 37107025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New multifunctional Ru(II) organometallic compounds show activity against Trypanosoma brucei and Leishmania infantum.
    Rivas F; Del Mármol C; Scalese G; Pérez-Díaz L; Machado I; Blacque O; Medeiros A; Comini M; Gambino D
    J Inorg Biochem; 2022 Dec; 237():112016. PubMed ID: 36244312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR).
    Francesconi V; Giovannini L; Santucci M; Cichero E; Costi MP; Naesens L; Giordanetto F; Tonelli M
    Eur J Med Chem; 2018 Jul; 155():229-243. PubMed ID: 29886325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.